January 12-15, 2026 | San Francisco Marriott Marquis, CA
We are a global biopharmaceutical company committed to leveraging courageous science, creativity, and compassion to deliver life-changing therapies. Leaders in targeted C3 therapies, we aim to develop transformative therapies.